Stock 4564 ONCOTHERAPY SCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News OncoTherapy Science, Inc.

Equities

4564

JP3202150003

Market Closed - Japan Exchange
Other stock markets
 07:00:00 30/05/2024 BST 		5-day change 1st Jan Change
26 JPY -13.33% Intraday chart for OncoTherapy Science, Inc. +18.18% +13.04%
04-29 Poland's Tusk calls prosecutor over potential Orlen scandal RE
04-22 OncoTherapy Science, Inc. cancelled the transaction announced on April 5, 2024 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Triple Negative Breast Cancer Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated)
AQ
Poland's Tusk calls prosecutor over potential Orlen scandal
RE
OncoTherapy Science, Inc. cancelled the transaction announced on April 5, 2024
CI
OncoTherapy Science, Inc. announced that it expects to receive ¥3.78 million in funding from Long Corridor Asset Management Limited and another investor
CI
Triple Negative Breast Cancer Pipeline, FDA Approvals, Clinical Trials Assessment, Companies 2023 | Shanghai Henlius Biotech, Jiangsu HengRui Medicine Co., Ltd., G1 Therapeutics, Inc., and others.
AQ
OncoTherapy Science, Inc.(TSE:4564) dropped from S&P Global BMI Index
CI
OncoTherapy Science, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023
CI
OncoTherapy Science, Inc. announced that it has received ¥95.95 million in funding
CI
OncoTherapy Science, Inc. announced that it expects to receive ¥95.95 million in funding
CI
OncoTherapy Science : Announcement of the Presentation of Interim Results for Phase I Clinical Study of a Combination of OTSGC-A24 and Immune Checkpoint Inhibitor in Patients with Gastric Cancer
PU
OncoTherapy Science, Inc. announced that it has received ¥12.25 million in funding from Daiwa Securities Co., Ltd., Investment Arm
CI
OncoTherapy Science, Inc. announced that it expects to receive ¥12.25 million in funding from Daiwa Securities Co., Ltd., Investment Arm
CI
OncoTherapy Science : Japanese bio-venture starts development of COVID-19 peptide vaccine
AQ
OncoTherapy Science, Inc. announced that it has received ¥12.013 million in funding from Daiwa Securities Group Inc.
CI
OncoTherapy Science, Inc. announced that it expects to receive ¥12.013 million in funding from Daiwa Securities Group Inc.
CI
Oncotherapy Science, Inc. and Theragen Etex Co.,Ltd., to Form Joint Venture Company
CI
OncoTherapy Science, Inc.(TSE:4564) added to Russell Global Index
CI
Split: 500 of 1
FA
OncoTherapy Science, Inc. Signs Licensing Agreement with Societe d'Exploitation de Produits pour les Industries Chimiques S.A
CI
Shionogi & Co. Signs Agreement with OncoTherapy Science Inc. for Cancer Peptide Vaccines
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4564 Stock
  4. News OncoTherapy Science, Inc.